<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-136351</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Hypertension secondary to treatment with latanoprost</dc:title>
<dc:description xml:lang="en">Case report: An 80 year old woman operated on by trabeculectomy for primary open-angle glaucoma due to increased pressure, who started treatment with latanoprost. Monitoring of blood pressure (BP) showed a statistically significant increase in both systolic and diastolic BP, coinciding with the use of topical hypotensive, which resolved by voluntarily suspending treatment, thus increasing again to reintroduce the prostaglandin. Discussion: Prostaglandin analogs reduce intraocular pressure to produce vasodilation of the episcleral and ciliary arteries, increasing the outflow of aqueous humor. Cardiovascular effects are rare, but have been described by the vasoconstrictor effect that can trigger the reversible increase in BP, as in this case (AU)</dc:description>
<dc:creator>García-Sánchez, J</dc:creator>
<dc:creator>García-Feijoo, J</dc:creator>
<dc:creator>Palmero-Fernández, L</dc:creator>
<dc:creator>García-Sáenz, S</dc:creator>
<dc:creator>Santos-Bueso, E</dc:creator>
<dc:creator>Sáenz-Francés, F</dc:creator>
<dc:creator>Martínez-de-la-Casa, J. M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso clínico: Mujer de 80 años intervenida mediante trabeculectomía por glaucoma primario de ángulo abierto en la que, debido al incremento tensional, se inició tratamiento con latanoprost. La monitorización de la tensión arterial (TA) demostró un incremento estadísticamente significativo de la TA tanto sistólica como diastólica coincidiendo con el uso del hipotensor tópico, que se resolvió al suspender voluntariamente el tratamiento, volviendo a elevarse al reintroducir la prostaglandina. Discusión: Los análogos de las prostaglandinas disminuyen la presión intraocular al producir vasodilatación de las arterias ciliares y epiesclerales, aumentando el drenaje del humor acuoso. Los efectos cardiovasculares son poco frecuentes pero se han descrito por el efecto vasoconstrictor que puede desencadenarse como el incremento reversible de la TA de este caso (AU)</dc:description>
<dc:source>Arch Soc Esp Oftalmol;90(1): 37-39, ene. 2015.</dc:source>
<dc:identifier>ibc-136351</dc:identifier>
<dc:title xml:lang="es">Hipertensión arterial secundaria a tratamiento con latanoprost</dc:title>
<dc:subject>^d3946^s22012</dc:subject>
<dc:subject>^d14190^s28898</dc:subject>
<dc:subject>^d14190^s37748</dc:subject>
<dc:subject>^d7152^s22044</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7152^s22012</dc:subject>
<dc:subject>^d7152^s22053</dc:subject>
<dc:subject>^d14190^s22045</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d28204^s22053</dc:subject>
<dc:subject>^d14190^s22074</dc:subject>
<dc:subject>^d28204^s22044</dc:subject>
<dc:subject>^d28204^s22012</dc:subject>
<dc:subject>^d7152^s22016</dc:subject>
<dc:subject>^d28204^s22016</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d3946^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>201501</dc:date>
</metadata>
</record>
</ibecs-document>
